Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
ISX:SIDO'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4.95 Med: 11.34 Max: 24.29
Current: 6.91
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of PT Industri Jamu dan Farmasi Sido Muncul Tbk was 24.29. The lowest was 4.95. And the median was 11.34.
ISX:SIDO's Price-to-Net-Current-Asset-Value is ranked worse than 68.09% of 1053
companies
in the Consumer Packaged Goods industry
Industry Median: 4.13
vs ISX:SIDO: 6.91
PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Net Current Asset Value Related Terms
PT Industri Jamu dan Farmasi Sido Muncul Tbk Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Net Current Asset Value Chart
PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
ISX:SIDO vs KHC, GIS: Net Current Asset Value Comparison
For the Packaged Foods subindustry, PT Industri Jamu dan Farmasi Sido Muncul Tbk's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Price-to-Net-Current-Asset-Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PT Industri Jamu dan Farmasi Sido Muncul Tbk's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where PT Industri Jamu dan Farmasi Sido Muncul Tbk's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of Rp53.86 mean?
PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) has a Net Current Asset Value of Rp53.86 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors. This is 375% above median its historical median of 11.34. Over the past decade, PT Industri Jamu dan Farmasi Sido Muncul Tbk's Net Current Asset Value has ranged from 4.95 to 24.29. According to the industry distribution chart, PT Industri Jamu dan Farmasi Sido Muncul Tbk ranks #717 out of 1053 companies in the Consumer Packaged Goods industry, placing it in the top 68.1%.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk's Net Current Asset Value too high?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Net Current Asset Value of Rp53.86 is 375% above median its 10-year median of 11.34. Over the past 10 years, this metric has ranged from a low of 4.95 to a high of 24.29. Based on the distribution chart, PT Industri Jamu dan Farmasi Sido Muncul Tbk ranks #717 out of 1053 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, PT Industri Jamu dan Farmasi Sido Muncul Tbk has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Industri Jamu dan Farmasi Sido Muncul Tbk's Net Current Asset Value compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, PT Industri Jamu dan Farmasi Sido Muncul Tbk ranks #717 out of 1053 companies for Net Current Asset Value. This places PT Industri Jamu dan Farmasi Sido Muncul Tbk in the lower half of its industry. The industry median Net Current Asset Value is 4.13. Historically, PT Industri Jamu dan Farmasi Sido Muncul Tbk's own Net Current Asset Value has ranged from 4.95 to 24.29 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Consumer Packaged Goods company?
The median Net Current Asset Value among Consumer Packaged Goods companies is 4.13, based on 1,053 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors. For the Consumer Packaged Goods industry, the median Net Current Asset Value is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Net Current Asset Value is Rp53.86, which is 375% above median its own 10-year median of 11.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp609.37, compared to a current price of Rp372.00 — trading 39% below its estimated fair value. The current Net Current Asset Value is Rp53.86, which is 375% above median its 10-year median of 11.34. PT Industri Jamu dan Farmasi Sido Muncul Tbk's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO), the current Net Current Asset Value is Rp53.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk stock appears to be undervalued.
The current stock price of Rp372.00 is trading 39% below its estimated GF Value™ of Rp609.37.
GuruFocus considers PT Industri Jamu dan Farmasi Sido Muncul Tbk to be Significantly Undervalued.
Key valuation signals for ISX:SIDO:
Net Current Asset Value: Rp53.86 (375% above median its 10-year median of 11.34)
GF Value™: Rp609.37 vs. price of Rp372.00 (39% below fair value)
No single metric tells the full story. See the ISX:SIDO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Business Description
PT Industri Jamu dan Farmasi Sido Muncul Tbk is focused on the herbal medicine and herbal products industry, with its products categorized into three distinct segments: Herbal Medicine and Supplements, Food and Beverages, and Pharmaceuticals. Its flagship herbal products include Tolak Angin, available in variants such as Tolak Angin Cair, Tolak Angin Cair Anak, Tolak Angin Sugar Free, Tolak Angin Batuk, and Tolak Angin Flu. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionery products. The Pharmacy segment sells pharmaceutical products, including Anacetine Syrup, Inflasone, Berlosid, Licokalk, and Licodexon. The majority of revenue is derived from the Herbal Medicine & Supplement segment.
81GF Score
Get the complete analysis for ISX:SIDO
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SIDO has been successfully added to your 
